Reversibility of Chronic Experimental Syndrome X by Diet Modification

Author:

Roberts Christian K.1,Vaziri Nosratola D.1,Liang Kai Hui1,Barnard R. James1

Affiliation:

1. From the Department of Physiological Science, University of California (C.K.R., R.J.B.), Los Angeles; and the Division of Nephrology and Hypertension, Department of Medicine, University of California (N.D.V., K.H.L.), Irvine.

Abstract

Abstract—This study was designed to examine whether abnormalities that comprise the metabolic syndrome, including insulin resistance, hyperinsulinemia, hypertension, hyperlipidemia, and obesity, are reversible by diet. Female Fischer rats were placed on either a high-fat, refined-carbohydrate (HFS) diet or low-fat, complex-carbohydrate (LFCC) diet for a period of 20 months. After 20 months, a group of HFS rats were switched to the LFCC diet (HFS/LFCC) for a period of 2 months. Skeletal muscle glucose transport, plasma insulin, systolic blood pressure, and plasma lipids were measured in all groups after 22 months. Energy intake and body weight were measured weekly. In the HFS group, insulin-stimulated glucose transport was significantly reduced (67±4 versus 98±4 pmol · mg1· 15 s1), whereas plasma insulin (300±49 versus 82±8 pmol/L), blood pressure (147±4 versus 123±4 mm Hg), plasma triglycerides (2.58±0.31 versus 0.39±0.04 mmol/L), LDL cholesterol (C) (3.45±0.40 versus 0.89±0.06 mmol/L), LDL-C to HDL-C ratio (2.9±0.1 versus 2.2±0.1), VLDL-C (1.53±0.23 versus 0.37±0.07 mmol/l), Total-C (5.56±0.58 versus 1.49±0.10 mmol/L), and body weight (360±11 versus 260±5 g) were all significantly elevated compared with the LFCC. Energy intake did not differ significantly; however, the LFCC had a much poorer feed efficiency. Conversion to a LFCC diet for 2 months led to normalization of glucose transport, blood pressure, plasma insulin, and VLDL-C and significant amelioration of obesity and other lipid abnormalities. These results demonstrate that syndrome X induced by an inappropriate diet is reversed with implementation of a low-fat, unrefined-carbohydrate diet without caloric restriction and suggest that diet may be a possible treatment for multiple simultaneous cardiovascular risk factors.

Publisher

Ovid Technologies (Wolters Kluwer Health)

Subject

Internal Medicine

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线,采集、加工和组织学术论文而形成的新型学术文献查询和分析系统,可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容,当前同舟云学术共收录了国内外主流学术期刊6万余种,收集的期刊论文及会议论文总量共计约1.5亿篇,并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询!咨询电话:010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号  京ICP备18003416号-3